Navigation Links
Drug May Dampen Dangerous Side Effect of Stem Cell Transplants
Date:12/1/2011

WEDNESDAY, Nov. 30 (HealthDay News) -- Preliminary research suggests that a drug typically used to kickstart the immune system may help cancer patients who receive stem cell transplants and then develop a potentially deadly side effect.

The drug appears to work by preventing the donor's immune system cells from overreacting to their new home and causing systemic inflammation.

Researchers found that daily low-dose injections of interleukin-2 appeared to help some patients by treating the side effect, known as graft-versus-host disease (GVHD).

Stem cell transplants can treat blood cancers such as leukemia. "More than half of patients who successfully undergo hematopoietic stem cell transplants [in which the blood-making tissue in the bone marrow is wiped out with chemotherapy and replaced with blood-forming stem cells from a donor] develop chronic GVHD," study author Dr. John Koreth, of Dana-Farber Cancer Institute in Boston, said in an institute news release. "The conventional treatment, glucocorticoids, are limited in their effectiveness and can produce significant side effects."

GVHD is "a big problem," said Dr. Gary Schiller, director of the Hematological Malignancies/Stem Cell Transplantation Unit at the Jonsson Comprehensive Cancer Center at the University of California, Los Angeles. Schiller was not involved with the study.

In the study, 12 of 23 patients who took the drug for eight weeks showed improvement in symptoms related to GVHD, including skin rash and other skin problems, hepatitis and inflamed lungs. The condition didn't worsen while the patients took the drug.

The study is the first phase of three stages of research that drug treatments must undergo before the federal government approves them to treat specific conditions. That means the findings are preliminary and may not be replicated in future research.

Schiller said the findings make sense. However, the treatment "has no impact, to my knowledge, on curing cancer. It only has an impact on decreasing the complications of the cancer cure."

The study, published in the Dec. 1 issue of the New England Journal of Medicine, was funded by several research grants and awards.

More information

For more about stem cells, visit the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCES: Gary Schiller, M.D., director, Hematological Malignancies/Stem Cell Transplantation Unit, Jonsson Comprehensive Cancer Center, University of California, Los Angeles; Dec. 1, 2011, New England Journal of Medicine; Dana-Farber Cancer Institute, news release, Nov. 30, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Gastric Bypass May Dampen Desire for High-Fat Foods
2. Patent awarded for method to dampen immune response
3. Surgery May Boost Survival With Dangerous Heart Condition
4. Tests to catch the makers of dangerous legal high designer drugs
5. Herbal supplements may cause dangerous drug interactions in orthopaedic surgery patients
6. Experts Point Out Signs of Dangerous Heart Rhythm
7. Diverticulitis Surgery More Dangerous for Older Black Patients: Study
8. Trauma experts criticize BBCs Holby City for peddling dangerous drugs
9. Dangerous Bacteria Hide Out in Nurses, Doctors Uniforms
10. Mobile Devices Dangerous for Pedestrians, Too
11. Antidepressant Tied to Dangerous Heart Rhythm: FDA
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug May Dampen Dangerous Side Effect of Stem Cell Transplants
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
Breaking Medicine Technology: